TFE3I - Overview: Transcription Factor E3 (TFE3) Immunostain, Technical Component Only
Assessment of transcription factor E3 expression
TIA1 - Overview: T-Cell Intracellular Antigen 1 (TIA-1) Immunostain, Technical Component Only
Characterizing neoplasms of cytotoxic T cells or natural killer cells
WNGC - Overview: West Nile Virus Antibody, IgG, Spinal Fluid
Aids in diagnosing recent or past central nervous system West Nile virus infection
ZNU - Overview: Zinc, 24 Hour, Urine
Identifying the cause of abnormal serum zinc concentrations using 24-hour urine specimens
Diagnosing fat malabsorption due to pancreatic or intestinal disorders Monitoring effectiveness of enzyme supplementation in certain malabsorption disorders This test is not useful for differentiating among pancreatic diseases.
TIS - Overview: Titanium, Serum
Monitoring metallic prosthetic implant wear
VITB3 - Overview: Vitamin B3 and Metabolites, Plasma
Assisting in the diagnosis of suspected vitamin B3 deficiency or toxicity May be useful in determining response to therapy
TGLBF - Overview: Triglycerides, Body Fluid
Distinguishing between chylous and nonchylous effusions Measurement of triglycerides in body fluids as a surrogate for chylomicrons
TRIG1 - Overview: Triglycerides, Serum
Managing atherosclerotic cardiovascular disease risk
TAUI - Overview: TAU Immunostain, Technical Component Only
Analysis of neurodegenerative disorders
Category A - Mayo Clinic Laboratories
How do I determine if my specimen is a Category A infectious substance affecting humans? See Category A Infectious Substances. By law, an......
Guidance on subtyping of influenza A test results - Insights
Mayo Clinic Laboratories’ guidance for subtyping influenza A in response to a CDC advisory for hospitalized patients...
Category A Infectious Substances - Mayo Clinic Laboratories
Category A Infectious Substances The Dangerous Goods section of the International Air Transport Association (IATA) website provides a "Classification of Infectious Substances" document (pdf)...
Testing for Antibodies to SS-A/Ro in Autoimmune Diseases - Insights
In this month’s “Hot Topic,” Anne Tebo, Ph.D., discusses recent updates in the testing for anti-SS-A/Ro antibodies in systemic autoimmune rheumatic diseases....
A recent Mayo Clinic study has found that many U.S. health care providers are habitually ordering a mostly unnecessary, and quite expensive, genetic test to identify a patient’s hereditary risk of venous...